WASHINGTON , March 1, 2024 /PRNewswire/ -- To kick off Obesity Care Week 2024, more than 60 advocates with the Obesity Action Coalition (OAC) will gather on Capitol Hill to meet with more than 70 legislators to express the importance of ...
First Patient Expected to be Randomized in the Second Quarter of 2024 CAMBRIDGE, Mass. , Feb. 29, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on ...
Preclinical Studies Show DA-1726 Elicits Superior Weight Loss Compared to Semaglutide (Wegovy™) and Similar Weight Loss Compared to Tirzepatide (Mounjaro™), While Consuming More Food Initiation of Phase 1 Clinical Trial Expected to Occur ...
CAMBRIDGE, Mass. , Dec. 28, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has submitted an ...
TAMPA, Fla. , Nov. 28, 2023 /PRNewswire/ -- The Obesity Action Coalition (OAC) announces the publication of a "Joint Statement in Support of Closing Gaps in the Drug Approval Process and Drug Labeling for People with Obesity." The ...
With over 100 million US adults experiencing obesity, and the condition accounting for $173 billion dollars in extra health costs annually, health tech company Theator set out to examine how bariatric surgeries are stacking up, only to find ...
Mazdutide demonstrates its differentiated advantages as a novel dual agonist of GLP-1 and GCG receptor with superior weight loss efficacy, significant improvement in a series of cardiometabolic indicators (waist circumferenc e, ...
WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Live-stream and In Person Event, October 11 , 2:00 – 4:00 PM, ET National Press Club, Washington DC , or live stream – register here: The State of Obesity: Creating Pathways to a ...
AD-9308 is a potent, and highly selective oral ALDH2 activator ready for IND-enabling development. AD-9308 treatment ameliorates diet-induced obesity and fatty liver, and improves glucose homeostasis in both male Aldh2 wild-type and Aldh2 ...
New patent covers methods to treat obesity using phenotyping. MENLO PARK, Calif. , Sept. 28, 2023 /PRNewswire/ -- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data-driven precision medicine ...
Soumya Swaminathan, former WHO Chief Scientist, highlights that the rise in abdominal obesity in India is largely due to unhealthy diets and a lack of physical activity, pointing to a significant public health concern ( ). ...
Essential need to preserve skeletal muscle mass when using GLP-1 receptor agonists for weight loss has been highlighted in the Lancet editorial. Although effective for obesity treatment, these medications raise concerns over the potential for ...
Expanding access to new and highly effective weight-loss medications could save over 40,000 deaths every year in the United States ( ). A recent study by the Yale School of Public Health and the University of Florida, explains the ...
New blood test has been developed that measures lipids to identify children at risk of obesity-related complications, including type 2 diabetes , liver disease , and heart disease , as per a study from King’s College London published in Nature ...
A BMJ investigation has uncovered a widespread lack of access to obesity care in England. Nearly half of the country's patients cannot see specialist weight loss teams, and...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers